[HTML][HTML] Modern biomarkers in prostate cancer diagnosis
P Porzycki, E Ciszkowicz - Central European journal of urology, 2020 - ncbi.nlm.nih.gov
Results Limited specificity of the prostate-specific antigen (PSA) test brings a need to
develop new and better diagnostic tools. In the last few years, new approaches for providing …
develop new and better diagnostic tools. In the last few years, new approaches for providing …
[PDF][PDF] Modern biomarkers in prostate cancer diagnosis
P Porzycki, E Ciszkowicz - academia.edu
Modern biomarkers in prostate cancer diagnosis Page 1 Central European Journal of
Urology 300 UROLOGICAL ONCOLOGY REVIEWPAPER Modern biomarkers in prostate …
Urology 300 UROLOGICAL ONCOLOGY REVIEWPAPER Modern biomarkers in prostate …
Modern biomarkers in prostate cancer diagnosis
P Porzycki, E Ciszkowicz - Central European Journal of …, 2020 - search.proquest.com
DRE has low sensitivity [3], while PSA is rather organ-, but not tumor-specific (low
specificity), and has a low positive predictive value (-30%)[4].[...] far, the final recognition …
specificity), and has a low positive predictive value (-30%)[4].[...] far, the final recognition …
Modern biomarkers in prostate cancer diagnosis.
P Porzycki, E Ciszkowicz - Central European Journal of Urology, 2020 - europepmc.org
Results Limited specificity of the prostate-specific antigen (PSA) test brings a need to
develop new and better diagnostic tools. In the last few years, new approaches for providing …
develop new and better diagnostic tools. In the last few years, new approaches for providing …
[PDF][PDF] Modern biomarkers in prostate cancer diagnosis
P Porzycki, E Ciszkowicz - pdfs.semanticscholar.org
Modern biomarkers in prostate cancer diagnosis Page 1 Central European Journal of
Urology 300 UROLOGICAL ONCOLOGY REVIEWPAPER Modern biomarkers in prostate …
Urology 300 UROLOGICAL ONCOLOGY REVIEWPAPER Modern biomarkers in prostate …
Modern biomarkers in prostate cancer diagnosis
P Porzycki, E Ciszkowicz - Central European journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Introduction The most common malignant neoplasm of the urinary tract is prostate cancer
(PCa), which is a heterogeneous disease, ranging from very slowly developing and slightly …
(PCa), which is a heterogeneous disease, ranging from very slowly developing and slightly …
[PDF][PDF] Modern biomarkers in prostate cancer diagnosis
P Porzycki, E Ciszkowicz - researchgate.net
Modern biomarkers in prostate cancer diagnosis Page 1 Central European Journal of
Urology 300 UROLOGICAL ONCOLOGY REVIEWPAPER Modern biomarkers in prostate …
Urology 300 UROLOGICAL ONCOLOGY REVIEWPAPER Modern biomarkers in prostate …